# NOVA Biologics, Inc. – FDA Inspection, Sep 16, 2026

Source: https://www.keypedia.com/records/fda_inspections/nova-biologics-inc/6d106ac2-31f6-4f0e-8204-5ce2740d1a4a
Source feed: FDA_Inspections

> FDA inspection 1287240 of NOVA Biologics, Inc., September 16, 2026. 6 citations under 21 CFR parts 606 and 610. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1287240
- Company Name: NOVA Biologics, Inc.
- Inspection Date: 2026-09-16
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Los Angeles District Office
- Citation Count: 6

## Related Documents

- FDA Inspection 1067663 - 2018-09-19
- FDA Inspection 788291 - 2012-06-27

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/melsomar-r-ramos/395e7ddc-ed98-455a-a143-0ee5f46804f4)

Company: https://www.keypedia.com/companies/nova-biologics-inc/c4ff9446-d9c1-4231-9e1d-53c1ddd91d31

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b